OCTAPHARMA 英语是什么意思 - 英语翻译

• octapharma

在 中文 中使用 Octapharma 的示例及其翻译为 英语

OctapharmaAG联系人.
Octapharma AG Contacts.

在过去五年中，Octapharma实现了强劲的增长，其复合年增长率达到了15%。
Over the last five years Octapharma has experienced strong growth with a compound annual growth rate of 15%.

Octapharma2018年年报.
Octapharma 2018 Annual Report.

全球血液制品市场集中度很高，发达国家的4家企业，CSLBehring、Baxter、Grifols、Octapharma等合计占据全球市场80%以上的份额。
The four enterprises of developed countries, CSL Behring, Baxter, Grifols and Octapharma, occupy over 80% of global market shares.

Octapharma集团2017年报.
Octapharma Group 2017 Annual Report.

计算在研发方面的投资，OctapharmaGroup在2015年对公司未来的投资超过了2.4亿欧元。
Adding the investments into research and development, in 2015 the Octapharma Group invested more than 240 million Euro into the future of the company.

OctapharmaGroup公布强劲的2018年业绩.
Octapharma Group reports strong results for 2018.

(美国商业资讯)-OctapharmaAG公司今日宣布正式启用其在德国海德堡投资的2500万欧元研究设施，致力于重组蛋白药物的开发。
(BUSINESS WIRE)-- Octapharma AG today announces the opening of a €25 million research facility dedicated to recombinant protein drug development in Heidelberg, Germany.

Octapharma实现了3.83亿欧元的运营收入，创历史新高。
Octapharma achieved an unprecedented operating income of €383 million.

及Octapharma均对中国出口人血白蛋白。
And Octapharma all export human serum albumin to China.

Octapharma在奥地利、法国、德国、瑞典和墨西哥拥有5家尖端技术生产厂。
Octapharma owns five state-of-the-art production facilities in Austria, France, Germany, Sweden and Mexico.

在加入Octapharma之前，Esat在StayinFront和MedProSystems担任执行销售职务。
Prior to Octapharma, Esat held executive sales positions at StayinFront and MedPro Systems.

Octapharma的愿景是“我们的激情驱动我们提供促进人类生活的新健康解决方案”。
The vision of Octapharma is"Our passion drives us to provide new health solutions advancing human life".

TimeLine:OctapharmaGroup公布2015年全年,收入达到3.51亿欧,收达到15亿欧元.
Octapharma Group publishes 2015 annual results reporting revenue of €1.5 billion and operating income of €351 million.

Octapharma的愿景是“我们的热忱激励我们提供新的健康解决方案，促进人类生命进步”。
The vision of Octapharma is“Our passion drives us to provide new health solutions advancing human life”.

OctapharmaGroup公布2016年业绩，录得营收16亿欧元，运营收入3.83亿欧元.
Octapharma Group publishes 2016 annual results reporting revenue of €1.6 billion and operating income of €383 million.

Octapharma集团发布2017年年报，公司实现了17.2亿欧元的营收，3.49亿欧元的运营收入.
Octapharma Group publishes 2017 annual results reporting revenue of €1.72 billion and operating income of €349 million.

Octapharma在人员、设备和资产方面投入了大量的资金，以应对产能和产量的增加。
Octapharma has been heavily investing in people, equipment and property to prepare for the increase in production capacity and volumes.

OctapharmaBiopharmaceuticals目前拥有46名员工，其现有的实验室和办公空间足以容纳120名员工。
Currently employing 46 people, Octapharma Biopharmaceuticals now has laboratory and office space for up to 120 staff.

Octapharma的北美销售额增长了18.8%，东欧增长了14%，西欧成熟市场增长了6%。
Octapharma achieved sales growth of 18.8% in North America, 14% in Eastern Europe and 6% in its well-established markets of Western Europe.

Octapharma采用“从人至人”的独特方法，使其在那些提供基于动物细胞系重组产品的公司中独树一帜。
Octapharma's unique approach, from human to human, sets the company apart from those recombinant products based on animal derived cell lines.

Octapharma在全球雇用了约8,314名员工，用以下三大领域的产品为115个国家病患的治疗提供支持：.
Octapharma employs around 8 000 people worldwide to support the treatment of patients in 113 countries with products across three therapeutic areas:.

Octapharma在全球雇用了约7,700名员工，用以下三大领域的产品为113个国家病患的治疗提供支持：.
Octapharma employs more than 7,100 people worldwide to support the treatment of patients in 113 countries with products across three therapeutic areas:.

Octapharma要感谢参与研究的所有人，特别是患者和家属，没有他们，这项研究是不可能完成的。
Octapharma would like to thank everyone involved in the study, in particular the patients and their families, without whom this research would not be possible.

Octapharma在全球雇用了约6,400名员工，用以下三大领域的产品为105个国家病患的治疗提供支持：.
Octapharma employs approximately 6,400 people worldwide to support the treatment of patients in 105 countries with products across three therapeutic areas:.

Octapharma公司有5,000多位员工，在包括美国在内的世界80个国家拥有生物制药经验，OctapharmaUSA位于新泽西州Hoboken。
Octapharma employs over 4,000 people and has biopharmaceutical experience in 80 countries worldwide, including the United States, where Octapharma USA is located in Hoboken.

Octapharma董事OlafWalter补充道：“此次变化是Octapharma不断致力于改善血友病群体生活的又一明证。
Olaf Walter, Board Member of Octapharma, added that“this change represents another mark of Octapharma's ongoing commitment to improving the lives of the haemophilia community”.